← Back to Clinical Trials
Recruiting NCT06598618

NCT06598618 Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06598618
Status Recruiting
Phase
Sponsor Riphah International University
Condition Patellofemoral Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2024-10-02
Primary Completion 2025-09-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Graston technique+ Conventional PTMuscle energy technique + Conventional PT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2024-10-02 with a primary completion date of 2025-09-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this randomized controlled trial is to compare the effect of Instrument Assisted Soft Tissue Mobilization (IASTM) and muscle energy technique on iliotibial band tightness on pain, range of motion and functional mobility in patients with patellofemoral pain syndrome.

Eligibility Criteria

Inclusion Criteria: * • Age between 18 and 35 years * Both Genders. * Anterior or retro patellar knee pain for at least the past 3 months. * Knee pain during at least 3 of the following activities: ascending/descending stairs, squatting, hopping/ running, and prolonged sitting. * Retro patellar pain in patellar grind test (positive clarke's sign). * A score of at least 3 on the visual analog scale (VAS). * Positive Ober's test. Exclusion Criteria: * • Any meniscal or ligament tears of knee. * Knee osteoarthritis. * Any previous surgery of lower limb. * Patellar fracture or fracture of lower extremity. * Having received knee injections of corticosteroids or hyaluronic acid. * Osteoporosis of knee joint.

Contact & Investigator

Central Contact

KINZA ANWAR, MS-OMPT

✉ kinza.anwar@riphah.edu.pk

📞 +92-3239735427

Principal Investigator

KINZA ANWAR, MS-OMPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06598618 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Patellofemoral Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06598618 currently recruiting?

Yes, NCT06598618 is actively recruiting participants. Contact the research team at kinza.anwar@riphah.edu.pk for enrollment information.

Where is the NCT06598618 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT06598618 clinical trial?

NCT06598618 is sponsored by Riphah International University. The principal investigator is KINZA ANWAR, MS-OMPT at Riphah International University. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology